Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 4 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: Q4QB65
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.507 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 211 | 213 | PF00675 | 0.418 |
CLV_PCSK_KEX2_1 | 211 | 213 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 227 | 229 | PF00082 | 0.358 |
CLV_PCSK_PC1ET2_1 | 227 | 229 | PF00082 | 0.450 |
CLV_PCSK_PC7_1 | 207 | 213 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.444 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 228 | 232 | PF00082 | 0.457 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.427 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.483 |
DEG_SCF_FBW7_1 | 289 | 296 | PF00400 | 0.516 |
DOC_CYCLIN_RxL_1 | 61 | 71 | PF00134 | 0.413 |
DOC_MAPK_gen_1 | 303 | 311 | PF00069 | 0.543 |
DOC_MAPK_gen_1 | 66 | 75 | PF00069 | 0.534 |
DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.372 |
DOC_USP7_MATH_1 | 293 | 297 | PF00917 | 0.527 |
DOC_USP7_MATH_1 | 44 | 48 | PF00917 | 0.686 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.490 |
DOC_USP7_UBL2_3 | 190 | 194 | PF12436 | 0.530 |
DOC_USP7_UBL2_3 | 227 | 231 | PF12436 | 0.580 |
DOC_WW_Pin1_4 | 289 | 294 | PF00397 | 0.514 |
DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.410 |
LIG_14-3-3_CanoR_1 | 173 | 177 | PF00244 | 0.424 |
LIG_14-3-3_CanoR_1 | 180 | 189 | PF00244 | 0.357 |
LIG_14-3-3_CanoR_1 | 193 | 197 | PF00244 | 0.278 |
LIG_14-3-3_CanoR_1 | 52 | 62 | PF00244 | 0.500 |
LIG_Actin_WH2_2 | 174 | 192 | PF00022 | 0.492 |
LIG_Actin_WH2_2 | 79 | 96 | PF00022 | 0.404 |
LIG_BIR_III_4 | 35 | 39 | PF00653 | 0.523 |
LIG_BRCT_BRCA1_1 | 260 | 264 | PF00533 | 0.453 |
LIG_FHA_1 | 173 | 179 | PF00498 | 0.485 |
LIG_FHA_1 | 266 | 272 | PF00498 | 0.518 |
LIG_FHA_1 | 284 | 290 | PF00498 | 0.386 |
LIG_FHA_1 | 334 | 340 | PF00498 | 0.619 |
LIG_FHA_1 | 63 | 69 | PF00498 | 0.384 |
LIG_FHA_1 | 83 | 89 | PF00498 | 0.290 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.431 |
LIG_FHA_2 | 243 | 249 | PF00498 | 0.495 |
LIG_LIR_Gen_1 | 248 | 258 | PF02991 | 0.422 |
LIG_LIR_Gen_1 | 316 | 327 | PF02991 | 0.576 |
LIG_LIR_Gen_1 | 71 | 80 | PF02991 | 0.477 |
LIG_LIR_Gen_1 | 98 | 107 | PF02991 | 0.608 |
LIG_LIR_Nem_3 | 142 | 148 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 248 | 253 | PF02991 | 0.551 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 98 | 103 | PF02991 | 0.608 |
LIG_SH2_CRK | 100 | 104 | PF00017 | 0.394 |
LIG_SH2_CRK | 72 | 76 | PF00017 | 0.448 |
LIG_SH2_GRB2like | 100 | 103 | PF00017 | 0.497 |
LIG_SH2_SRC | 254 | 257 | PF00017 | 0.444 |
LIG_SH2_STAP1 | 229 | 233 | PF00017 | 0.500 |
LIG_SH2_STAP1 | 254 | 258 | PF00017 | 0.379 |
LIG_SUMO_SIM_anti_2 | 255 | 261 | PF11976 | 0.304 |
LIG_SUMO_SIM_par_1 | 174 | 179 | PF11976 | 0.412 |
LIG_SUMO_SIM_par_1 | 285 | 292 | PF11976 | 0.504 |
LIG_TYR_ITIM | 70 | 75 | PF00017 | 0.480 |
LIG_TYR_ITSM | 96 | 103 | PF00017 | 0.490 |
LIG_WRC_WIRS_1 | 148 | 153 | PF05994 | 0.476 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.505 |
MOD_CK1_1 | 112 | 118 | PF00069 | 0.565 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.434 |
MOD_CK1_1 | 332 | 338 | PF00069 | 0.745 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.429 |
MOD_CK2_1 | 207 | 213 | PF00069 | 0.560 |
MOD_CK2_1 | 242 | 248 | PF00069 | 0.501 |
MOD_Cter_Amidation | 191 | 194 | PF01082 | 0.471 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.613 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.660 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.549 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.531 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.600 |
MOD_GSK3_1 | 283 | 290 | PF00069 | 0.443 |
MOD_GSK3_1 | 293 | 300 | PF00069 | 0.541 |
MOD_GSK3_1 | 327 | 334 | PF00069 | 0.606 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.723 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.408 |
MOD_N-GLC_1 | 40 | 45 | PF02516 | 0.591 |
MOD_N-GLC_2 | 102 | 104 | PF02516 | 0.448 |
MOD_N-GLC_2 | 116 | 118 | PF02516 | 0.506 |
MOD_NEK2_1 | 223 | 228 | PF00069 | 0.648 |
MOD_NEK2_1 | 264 | 269 | PF00069 | 0.411 |
MOD_NEK2_1 | 327 | 332 | PF00069 | 0.631 |
MOD_NEK2_1 | 333 | 338 | PF00069 | 0.605 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.609 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.427 |
MOD_NEK2_2 | 192 | 197 | PF00069 | 0.427 |
MOD_PIKK_1 | 258 | 264 | PF00454 | 0.379 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.415 |
MOD_PKA_2 | 192 | 198 | PF00069 | 0.372 |
MOD_Plk_1 | 141 | 147 | PF00069 | 0.482 |
MOD_Plk_2-3 | 172 | 178 | PF00069 | 0.422 |
MOD_Plk_4 | 238 | 244 | PF00069 | 0.485 |
MOD_Plk_4 | 68 | 74 | PF00069 | 0.465 |
MOD_ProDKin_1 | 289 | 295 | PF00069 | 0.509 |
MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.415 |
MOD_SUMO_rev_2 | 153 | 160 | PF00179 | 0.466 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.461 |
TRG_ENDOCYTIC_2 | 145 | 148 | PF00928 | 0.463 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 280 | 283 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.428 |
TRG_ER_diArg_1 | 133 | 136 | PF00400 | 0.562 |
TRG_ER_diArg_1 | 302 | 305 | PF00400 | 0.531 |
TRG_NES_CRM1_1 | 172 | 186 | PF08389 | 0.459 |
TRG_Pf-PMV_PEXEL_1 | 187 | 191 | PF00026 | 0.521 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6C0 | Leptomonas seymouri | 34% | 100% |
A0A3S7WXR6 | Leishmania donovani | 89% | 100% |
A4HCW7 | Leishmania braziliensis | 55% | 100% |
A4I0E7 | Leishmania infantum | 89% | 100% |
E9AWB0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |